
ISMP Newsroom
ISMP
Media Inquiries
For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.
News

Failure to Track Diagnostic Results Puts Patients at Risk
ECRI Institute’s Partnership for Health IT Patient Safety releases whitepaper and guide for closing the loop on diagnostic testing and referrals.
Read moreNews

ISMP Warns that Medical Marijuana Product Labeling Problems Have Led to Errors
As state legalization of medical marijuana sales spreads, issues have arisen with confusing product labeling that has led to errors.
Read moreNews

Two Patient Safety Leaders Announce Formal Affiliation
ECRI Institute and the Institute for Safe Medication Practices (ISMP) announce the successful completion of their plans to join forces. Effective today, ISMP is an ECRI Institute affiliate.
Read moreNews

ECRI Institute and Institute for Safe Medication Practices Join Forces to Enhance Patient Safety
ECRI Institute and the Institute for Safe Medication Practices (ISMP) announce they are joining forces to create one of the largest patient safety entities in the world.
Read morePress Coverage

Taking a Closer Look at a Fatal Vecuronium Error
This article appeared on the Anesthesiology News website on February 19, 2019.
Read moreNews

ISMP Calls for a System-Based Response to Errors, Not Criminal Prosecution
In the wake of recent criminal charges being filed against a registered nurse in Tennessee who was involved in a fatal medication error, ISMP is emphasizing that the focus should be on identifying ...
Read moreStay Connected
Get medication safety news, event invitations and updates straight to your inbox!
Social Media
View the Latest from ECRI

ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award
Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...
Read more
ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides
The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...
Read more